Identification was done with the EVA program (BRUKER / SIEMENS) and the PDF datafile.
 
SMRR1:
The first run with search for "minerals" and no further limitations give:
Fluorapatite
Siderite
Gormanite (better: a member of Gormanite-Souzalite series)
Quartz

In a further run with special search for minerals with P and O and after removing all the apatite phases from the list an additional minor phase could be identified:
A member of Ferroalluaudite-Alluaudite series.

 
 
SMRR2:
The identification was unsuccesful.
(no attached file)
 
 
SMRR3:
We are not familiar with the identification of organic compounds and substances produced by pharmaceutical engineers, and the results of the search routine were not so obvious that a clear identification is possible, therefore I would consider the results or at least parts of the results as questionable:
Thalidomide  (19-1946)
N-(2,3-Dihydroxyphenylmethylene)-4 sulfamidobenzeneamine  (47-1925) 
6-Amino-phenalenone-6-amino-1H-phenalen-1-one  (45-1544)    ???
apparently additional (ore other) phases are present.
 
 
SMRR4:
The first run with search for "inorganic" and "minerals" and no further limitations give:
Lead Oxide Sulfate  Pb5O4SO4  (23-0333)
Litharge   (05-0561)

In a second run with special search for Pb compounds an additional minor phase could be identified:
Lead Oxide Sulfate Hydrate  Pb4O3SO4 x H2O  (29-0781)